Asset Details
Do you wish to reserve the book?
Prioritization of prognostic biomarkers regulated by calorie restriction in colon cancer through integrated biosignature analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Prioritization of prognostic biomarkers regulated by calorie restriction in colon cancer through integrated biosignature analysis
Do you wish to request the book?
Prioritization of prognostic biomarkers regulated by calorie restriction in colon cancer through integrated biosignature analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Prioritization of prognostic biomarkers regulated by calorie restriction in colon cancer through integrated biosignature analysis
2025
Overview
Colorectal cancer (CRC) remains a critical global health challenge, ranking second in cancer-related mortality and third in cancer incidence as of 2018, with risk increasing with age. Addressing its rising burden requires early diagnosis, prognostic biomarkers, and effective therapeutic strategies. Emerging evidence suggests that calorie restriction may mitigate aging-related functional decline and influence CRC progression, yet the molecular markers and mechanisms remain poorly understood. In this study, we analyzed the GSE24432 dataset, using multiple computational databases to screen differentially expressed genes (DEGs) associated with calorie restriction in CRC. Functional annotations, including Gene Ontology (GO), KEGG pathway analysis, and gene set enrichment analysis (GSEA), were undertaken to explore potential underlying mechanisms and pathways in CRC pathogenesis. Kaplan Meier and Cox proportional hazards regression analyses were conducted to establish the diagnostic and prognostic significance of the hub genes. The validation test was conducted via multiple databases. Our investigation identified 50 DEGs, using the cutoff criteria,
p
. adj < 0.05, |log2FC|> 0.3. GO and functional analysis results revealed extensive crosstalk of cellular and molecular components and pathways associated with mRNA and ribosome biogenesis, AMPK signaling, and p53 signaling pathway following calorie restriction. To understand how these DEGs drive biological reactions, we sorted the genes according to gene score > 3 and GO term > 3 and obtained 14 DEGs most relevant to the GO terms. Further analysis with GO CHORD showed that most genes are enriched in ribosome biogenesis and protein synthesis. Gene set enrichment analysis (GSEA) revealed the involvement of the hub genes in several hallmarks, such as tissue invasion and metastasis (
p
< 0.001), tumor-promoting inflammation (
p
< 0.001), resisting cell death (
p
< 0.01), and replicative immortality (
p
< 0.05). Survival analysis showed that higher expression of 7 hub genes,
CDKN2A
(
p
< 0.05), RPL9 (
p
< 0.02),
TUBB6
(
p
< 0.01), and
RPS15A
(
p
< 0.01), and lower expression of
CDKN1B
(
p
< 0.01),
NPM1
(
p
< 0.01), and
RALA
(
p
< 0.01), correlated to shorter survival of colon cancer. However, cross-reference of these genes revealed that calorie restriction decreased the expressions of
CDKN2A
and
TUBB6
while
CDKN1B
and
NPM1
were increased (
p
< 0.05). Several validation tests from multiple databases showed that high
CDKN2A
is associated with shorter overall survival rates, indicating
CDKN2A
is a therapeutic target and could serve as a more reliable biomarker for CRC prognosis. These findings could potentially facilitate the development of precision-based energy restriction interventions for CRC management, offering promising prospects for targeted therapeutic strategies for CRC patients.
Publisher
Springer International Publishing,Springer Nature B.V
Subject
/ Biomarkers, Tumor - genetics
/ Calories
/ Colonic Neoplasms - diet therapy
/ Colonic Neoplasms - genetics
/ Colonic Neoplasms - mortality
/ Colonic Neoplasms - pathology
/ Computational Biology - methods
/ Datasets
/ Diet
/ Gene Expression Regulation, Neoplastic
/ Gene set enrichment analysis
/ Humans
/ Medicine
/ mRNA
/ Obesity
/ Oncology
/ Ontology
/ Patients
/ Proteins
/ Tumors
